Trial · NCT02134314
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients Enrolled With Serum Creatinine >3mg/dL on Postoperative Day 5. | C1-Inhibitor (Berinert) (Human) (C1INH) | 29 | Participants | ||
| Number of Patients Enrolled With Serum Creatinine >3mg/dL on Postoperative Day 5. | Normal Saline | 32 | Participants | ||
| Number of Patients Enrolled Who Require at Least One Session of Dialysis in the First 7 Days Post Transplant. | C1-Inhibitor (Berinert) (Human) (C1INH) | 15 | Participants | ||
| Number of Patients Enrolled Who Require at Least One Session of Dialysis in the First 7 Days Post Transplant. | Normal Saline | 21 | Participants | ||
| Number of Patients With Serum Creatinine Reduction Ratio of < 30% From 24 to 48 Hours Post-transplant. | C1-Inhibitor (Berinert) (Human) (C1INH) | 30 | Participants | ||
| Number of Patients With Serum Creatinine Reduction Ratio of < 30% From 24 to 48 Hours Post-transplant. | Normal Saline | 28 | Participants | ||
| Number of Dialysis Sessions Per Patient in the First 7 Days Post Transplant. | C1-Inhibitor (Berinert) (Human) (C1INH) | 0.97 | Standard Deviation 1.22 | dialysis sessions | |
| Number of Dialysis Sessions Per Patient in the First 7 Days Post Transplant. | Normal Saline | 1.54 | Standard Deviation 1.54 | dialysis sessions | |
| Serum Creatinine | C1-Inhibitor (Berinert) (Human) (C1INH) | 1.3 | Standard Deviation 0.317 | mg/dL | |
| Serum Creatinine | Normal Saline | 1.7 | Standard Deviation 1.410 | mg/dL | |
| Creatinine Clearance | C1-Inhibitor (Berinert) (Human) (C1INH) | 56.4 | Standard Deviation 15.558 | ml/minute | |
| Creatinine Clearance | Normal Saline | 51.2 | Standard Deviation 17.335 | ml/minute | |
| 24h Urine Output | C1-Inhibitor (Berinert) (Human) (C1INH) | 873.5 | Standard Deviation 1257.0 | milliliters | |
| 24h Urine Output | Normal Saline | 607.8 | Standard Deviation 782.4 | milliliters | |
| Mean Number of Patients on Dialysis | C1-Inhibitor (Berinert) (Human) (C1INH) | 0 | Participants | ||
| Mean Number of Patients on Dialysis | Normal Saline | 5 | Participants | ||
| Number of Patients With Delayed Graft Function (DGF) (Categorized by DGF Scale) | C1-Inhibitor (Berinert) (Human) (C1INH) | 15 | Participants | ||
| Number of Patients With Delayed Graft Function (DGF) (Categorized by DGF Scale) | Normal Saline | 21 | Participants | ||
| Overall Incidence of Serious Adverse Events | C1-Inhibitor (Berinert) (Human) (C1INH) | 11 | events | ||
| Overall Incidence of Serious Adverse Events | Normal Saline | 16 | events |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02134314/results